Clinical Trials Logo

Area Under Curve clinical trials

View clinical trials related to Area Under Curve.

Filter by:
  • None
  • Page 1

NCT ID: NCT06095895 Not yet recruiting - Pharmacokinetics Clinical Trials

Model Informed preciSion doSIng tO iNdividualise and Optimize Pharmacotherapeutic Treatment

MISSION
Start date: November 15, 2023
Phase:
Study type: Observational

This is a prospective observational study of MIPD in clinical practice for paediatric kidney transplant patients using tacrolimus and mycophenolic acid in Radboudumc. Dose individualization in paediatric kidney transplant patients using the InsightRX platform is performed as standard care, meaning that a pharmacokinetic model and drug levels measured at t=0, t=1 and t=2 hours will be used to calculate the exposure. Based on the estimated exposure, the pharmacist gives a dose recommendation to the physician, who can then modify the dosage of mycophenolic acid or tacrolimus. The selected dose and the measured MPA and tacrolimus concentrations will be used to predict the future exposure. A second exposure measurement will be performed to evaluate whether our model is able to predict future exposure.

NCT ID: NCT05114551 Recruiting - Critical Care Clinical Trials

ICU Predictive Score of WEaning Success in Patients At Risk of Extubation Failure

I-SWEAR
Start date: September 28, 2021
Phase:
Study type: Observational

Observational study in two medical-surgical intensive care units of the Clermont-Ferrand University Hospital to develop a composite score for prediction of 72h-extubation failure in patients at risk of extubation failure.

NCT ID: NCT04756895 Completed - Adult Clinical Trials

Vancomycin Dose Adjustments Comparing Trough Levels to The AUC/MIC Method Using a Bayesian Approach in a Hospitalized Adult Population

VancoDATABayes
Start date: March 1, 2021
Phase: N/A
Study type: Interventional

This pilot study is a prospective, randomized, controlled, open-label trial to assess the feasibility of a randomized controlled trial of sufficient quality that would assess the efficacy and safety of vancomycin adjustments according to Area under the curve/Minimal inhibitory concentration (AUC0-24h/MIC) calculated by the Bayesian approach rather than by a trough dosage. Randomization will be stratified according to infection severity. Approximately 60 subjects meeting all inclusion and no exclusion criteria will be randomized to have pharmacists perform vancomycin dose adjustments with AUC0-24h / MIC calculated by the Bayesian approach versus the trough dosage approach.

NCT ID: NCT03857230 Completed - Pharmacokinetics Clinical Trials

The Safety and Pharmacokinetics of Primapur and Gonal-f

Start date: October 29, 2015
Phase: Phase 1
Study type: Interventional

The purpose of the current phase I study was to establish bioequivalence, safety, and tolerance of single 300 IU subcutaneous dose of follitropin alfa biosimilar (Primapur) in comparison to that of reference follitropin alfa preparation (Gonal-F) in healthy young female volunteers.

NCT ID: NCT02292420 Completed - Area Under Curve Clinical Trials

The Normal Reference Values of Pulse Oximetry Plethymographic Waveform Parameters

Start date: October 2014
Phase: N/A
Study type: Observational

The purpose of this study is to determine the normal reference values of pulse oximetry plethymographic waveform parameters in Chinese population.